BPMC
Blueprint Medicines Corp
Price:  
129.46 
USD
Volume:  
2,931,708.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BPMC Relative Valuation

-125.3%
Upside

As of 2025-07-19, the Relative Valuation of Blueprint Medicines Corp (BPMC) is (32.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 129.46 USD, the upside of Blueprint Medicines Corp based on Relative Valuation is -125.3%.

The range of the Relative Valuation is (32.02) - (33.90) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.3x - 14.1x 13.7x
Forward P/E multiples 12.8x - 14.3x 13.5x
Fair Price (32.02) - (33.90) (32.80)
Upside -124.7% - -126.2% -125.3%
129.46 USD
Stock Price
(32.80) USD
Fair Price

BPMC Relative Valuation - Historical P/E Data

Date P/E
2025-07-17 -53.69
2025-07-16 -53.61
2025-07-15 -53.64
2025-07-14 -53.64
2025-07-11 -53.62
2025-07-10 -53.63
2025-07-09 -53.31
2025-07-08 -53.25
2025-07-07 -53.25
2025-07-03 -53.23
2025-07-02 -53.16
2025-07-01 -53.22
2025-06-30 -53.16
2025-06-27 -53.13
2025-06-26 -53.14
2025-06-25 -53.18
2025-06-24 -53.19
2025-06-23 -53.25
2025-06-20 -53.16
2025-06-18 -53.13
2025-06-17 -53.18
2025-06-16 -53.18
2025-06-13 -53.06
2025-06-12 -53.17
2025-06-11 -53.06
2025-06-10 -53.07
2025-06-09 -53.07
2025-06-06 -53.02
2025-06-05 -53.04
2025-06-04 -53.12
2025-06-03 -52.91
2025-06-02 -52.99
2025-05-30 -42.03
2025-05-29 -42.74
2025-05-28 -39.52
2025-05-27 -41.49
2025-05-23 -42.09
2025-05-22 -41.61
2025-05-21 -42.10
2025-05-20 -42.71
2025-05-19 -41.97
2025-05-16 -42.17
2025-05-15 -41.26
2025-05-14 -40.44
2025-05-13 -41.22
2025-05-12 -41.60
2025-05-09 -40.30
2025-05-08 -40.95
2025-05-07 -41.39
2025-05-06 -41.12